Apollon Wealth Management LLC raised its position in shares of Global X Uranium ETF (NYSEARCA:URA – Free Report) by 98.3% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 20,093 shares of the company’s stock after acquiring an additional 9,961 shares during the period. Apollon Wealth Management LLC’s holdings in Global X Uranium ETF were worth $780,000 at the end of the most recent quarter.
A number of other institutional investors also recently made changes to their positions in URA. Reyes Financial Architecture Inc. acquired a new stake in shares of Global X Uranium ETF in the second quarter valued at approximately $25,000. Strategic Investment Solutions Inc. IL acquired a new stake in shares of Global X Uranium ETF in the first quarter valued at approximately $30,000. Banque Transatlantique SA acquired a new stake in shares of Global X Uranium ETF in the first quarter valued at approximately $35,000. MAI Capital Management acquired a new stake in shares of Global X Uranium ETF in the first quarter valued at approximately $37,000. Finally, Militia Capital Partners LP acquired a new stake in shares of Global X Uranium ETF in the first quarter valued at approximately $44,000.
Global X Uranium ETF Trading Up 2.0%
NYSEARCA URA opened at $58.11 on Thursday. Global X Uranium ETF has a 1-year low of $19.50 and a 1-year high of $60.51. The company has a 50 day moving average of $44.63 and a 200-day moving average of $36.21. The company has a market cap of $6.32 billion, a price-to-earnings ratio of 37.39 and a beta of 1.09.
About Global X Uranium ETF
The Global X Uranium ETF (URA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-weighted index of companies involved in uranium mining and the production of nuclear components. URA was launched on Nov 4, 2010 and is managed by Global X.
See Also
- Five stocks we like better than Global X Uranium ETF
- How to Invest in Blue Chip Stocks
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Options Trading – Understanding Strike Price
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- What Are Dividend Challengers?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Global X Uranium ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X Uranium ETF and related companies with MarketBeat.com's FREE daily email newsletter.